Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Boehringer Ingelheim
Seagen Inc.
Genmab
Merck Sharp & Dohme LLC
Hoffmann-La Roche
Servier
University of Chicago
Seagen Inc.
AstraZeneca
Eli Lilly and Company
Pfizer
Servier
Genmab
Merck Sharp & Dohme LLC
Charite University, Berlin, Germany
M.D. Anderson Cancer Center
Arcus Biosciences, Inc.
Merck Sharp & Dohme LLC
MedSIR
M.D. Anderson Cancer Center
Immunocore Ltd
Merck Sharp & Dohme LLC
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
ModernaTX, Inc.
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Memorial Sloan Kettering Cancer Center
Genmab
Genmab
Eastern Cooperative Oncology Group
VA Office of Research and Development
UNICANCER